The obesity and diabetes epidemics are driving the NAFLD epidemic. Although the overall risk of HCC in NAFLD is lower than in liver disease of different etiology, the very high number of cases will constitute a worldwide challenge for National Health Systems. The diabetes-associated progression of NASH/cryptogenic cirrhosis to HCC is slow, but effective treatments are limited by comorbidities, which also reduce the inclusion in liver transplant lists. New diabetes treatments might help decrease the future burden of diabetes-associated HCC.
Diabetes and hepatocellular cancer risk: not only a matter of hyperglycemia
MARCHESINI REGGIANI, GIULIO;FORLANI, GABRIELE
2012
Abstract
The obesity and diabetes epidemics are driving the NAFLD epidemic. Although the overall risk of HCC in NAFLD is lower than in liver disease of different etiology, the very high number of cases will constitute a worldwide challenge for National Health Systems. The diabetes-associated progression of NASH/cryptogenic cirrhosis to HCC is slow, but effective treatments are limited by comorbidities, which also reduce the inclusion in liver transplant lists. New diabetes treatments might help decrease the future burden of diabetes-associated HCC.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
